Member Info for Vascular

Also, Can someone just confirm with me that todays share price of approx. £1.25 is just 0.0065p in old money! even with the recent rise, 0.0065 seems very cheap. Am i correct ?

Thanks for feedback all.
I unfortunately missed the presentation today as at work, now have a break so...
I posted two questions today and i am wondering whether either were mentioned...

1) Will FDBK work with Qure.ai in other regions of the world and with other types of medical conditions, other than TB ?
and
2) What sort of revenue will CareLocker eventually produce in India ...is it per patient or per diagnostic centre? Example?

Sounds like a very positive presentation . Cheers Vas

I liked the fact he acknowledged that organisations in the NHS tend to spend big towards the end of the financial year!

Meaning, i guess that there could be a small procurement frenzy as organisations ensure their budgets are depleted before the next financial year round of financing.

Excellent find old tramp. Looking v. good

Recent debate on Virtual Wards which IMO will be increased significantly over this and future years....and as with most things in life its "Communication" between everyone involved (professionals and the patient) that will be most important to get right, so to identify any change in the patients condition quickly.
There is definitely an opportunity with Bleepa and Carelocker in this space.

https://www.emjreviews.com/innovations/congress-review/pioneering-patient-care-clinical-networks-and-digital-health-solutions-j080123/

I think with an Analyst presentation tomorrow, followed by an Investors Presentation they must have some exciting developments . Its not the sort of thing a company will do when all they have is a relate back exercise to the what is already know from previous updates.
Unfortunately, another nurses strike tomoz, and I'm working, so will miss any highlights at the 4pm Investors meet.

Please can anyone post up any significant developments . It would be much appreciated.

If you re read the December 2022 half Year Trading update there are several areas where they are in "conversations" with third party's so would expect more about these tomorrow. Sampurna Sodani Diagnostic look like a good bet in India.
IMO. GL Vas

Evening oldtramp.

I have also had a quick scan of the other company's in FDBKS group ( Lot 1b - Artificial Intelligence Platforms) and came to the same conclusion as you , its quite a mixed bag of offerings , some specific and others more wide ranging.
( good observation about CareLocker also).

I did notice Agfa HealthCare IT UK Ltd are now SO 27001 certificated and Blackford Analysis ltd was only certified ISO 27001, last week !

"A cross functional Blackford project team has been busy working throughout 2022 to incorporate the ISO 27001:2013 standard requirements into our existing ISO 13485:2016 and ISO 9001:2015 compliant Management System.

We’re delighted to see the fruits of these labours rewarded as we had our certification audit 23-25 Jan 2023 and received our certification on 27 Jan 2023!

ISO 27001 is the only auditable international standard that defines the requirements of an ISMS (Information Security Management System).

An?ISMS?is a systematic approach consisting of processes, technology and people that helps you protect and manage all your organisation’s information through effective risk management.

At the heart of our ISO 27001-compliant Management System are business-driven risk assessments, used to identify and treat security threats.

So you can be sure that at Blackford, we take our security and compliance seriously!"

https://www.blackfordanalysis.com/blackford-is-now-iso-27001-certified/
https://global.agfahealthcare.com/regulatory-compliance/

Anyway, good luck for this week,. Vas.

I guess the best way to identify the competition for FDBK in UK is to look at the most recent Framework agreement with NHS Shares Business which states the framework will be from 14th September 2021 to 13 September 2023
(optional 24-month extension until 13 September 2025.

Feedback have been placed in a group called Lot 1b - Artificial Intelligence Platforms.

It looks lie FDBK are up against the following names in their group.

Lot 1b - Artificial Intelligence Platforms

Agfa HealthCare IT UK Ltd
Blackford Analysis Limited
Hermes Medical Solutions
Aidoc Medical Ltd
Blackford Analysis Limited
Perspectum Ltd
Artrya
Feedback Medical
Philips Electronics UK Limited

Be worth keeping an eye on these other company's to see if they announce any wins, where, and for how much.
https://sbs.nhs.uk/fas-artificial-intelligence-radiotherapy

Confirmation that QVH is using SECTRA ( tender won in early 2022) and we know BLEEPA were conducing their pilot at this time. :)

https://www.digitalhealth.net/2022/01/surrey-and-sussex-sectra/

Hi PR, yes that's the post i remember, even though it is over two years old, its good to hear clarification.

Today, i am just relieved that we have an identified live case in QVH, who are using SECTRA along side their pilot with FDBK's BLEEPA. Plus the tender outcome shortly.
Its very easy to imagine how this company could do very well, and fast when other trusts ( most likely using SECTRA PACS) look at QVH's solution using SECTRA and BLEEPA and see the added value that BLEEPA offers.

I am not trying to look for trouble, but SPECTRA seem to be everywhere in Uk.

On the plus side , i just looked up Queen Victoria Hospital NHS Foundation Trust to see who their most recent PACS supplier was. Just a year ago they tendered. And guess what ? It was SECTRA lol
"The Surrey and Sussex trusts will be joining Barts Health NHS Trust and Greater Manchester’s Pennine Acute Hospital NHS Trust in signing recent deals with Sectra".

https://www.digitalhealth.net/2022/01/surrey-and-sussex-sectra/

So, I feel much more confident now knowing that we must be working alongside SECTRA with QVH, in order to roll out BLEEPA.

Just need to get that QVH tender under our belt.

Anyone reading the publication below from Sectra would be forgiven in thinking that either Sectra have access to BLEEPA or Sectra have their own offering which competes with BLEEPA.

Bearing in mind that someone ( sorry, forgot who) emailed Tom, a few months ago asking if SECTRA was a competitor of Bleepa. Toms reply was posted here, reply being no, BEEPA works to compliment SECTRAs offering, or something similar.

SECTRA are dominating the PACS space in UK from the look of it. Their contracts comprise their digital pathology module of the enterprise imaging subscription service Sectra One Cloud..
headlines such as these below as an example ....

East of England trusts to digitize pathology following a cloud service contract with Sectra
https://sectra.com/news-and-press-releases/?item=E86B37ED65DB9AD6

Kent NHS trusts in the UK to modernize patient diagnostics with Sectra in a multi-hospital collaborative environment

Sectra and Greater Manchester sign deal for one of the largest region-wide imaging initiatives in Europe

The National Pathology Imaging Co-operative, NPIC, opens opportunities for NHS trusts throughout the country to digitise pathology and improve patient diagnoses, following new funding and expanding the usage of Sectra’s digital pathology solution and VNA. The agreement follows a separate November announcement from the UK government that commits £248 million over the next year to help modernise NHS diagnostics using the latest technology.

There are others..

Have a read of this article below. What's everyone's opinion! Competition or possible partner?

Any hint that we are involved with SECTRA and this share will blow IMO GL Vas

https://medical.sectra.com/case/enterprise-digital-imaging-with-sectra-pacs-at-morecambe-bay/

https://medical.sectra.com/case/enterprise-digital-imaging-with-sectra-pacs-at-morecambe-bay/

Good find Barnacle.
It all pointing to expansion in India as well as UK.

https://issuu.com/thetradeagency/docs/hw008_w_

Published 25th Jan. 23

Feedback Medical appear on pages 64/5

Couple of things stood out, were they mentioned working with Mental Health Trusts in UK and also a quote from Tom "Our Initial pilot ( in India) started in March 22, identified signs of TB in around 21% of patients scanned in its first five months".

What will be interesting is if Fdbk get on a tipsheet in the coming weeks ....quire possible if next weeks update positive.

I totally agree with you I. Bill. Its an investors dream to be in on the ground floor of a good company that actually achieves what it sets out to do....AIM is full of good story's, most will never happen, IF, it all goes to plan we would have much more to gain in holding on to our shares long term.
I've ben a round AIM to long to think I can pick a winner, I've picked loads over the years...all failed in some way to achieve their potential . A few, much fewer winners as well.
My feelings about FDBK is its a achieved a lot these past 18 months and i somehow think, post Covid the "Zeitgeist " is walking hand in hand with them, hopefully :) GL Vas.

Evening Oldtramp,

Yes, anything is possible. Imagine that first thing on Tuesday Morning before the meeting. Probably to much to ask for!
Best not get to disheartened if we don't get it, as they say you cant win them all, but it will flag up one of our main competitors in this space, something i am interested in, even though it seems we have been told there are none that can compete with BLEEPA. We will find out next week, I guess.
Not uncommon for a competitor to buy out another, especially if FDBK start winning contracts with such a small market cap, and plenty of cash and possibility of alliances with big partners such as Qure.ai with possible future world wide contracts with governments and organisations.

Axial3D opens new Medical 3D Printing Centre of Excellence

https://www.3dprintingmedia.network/axial3d-opens-new-medical-3d-printing-centre-of-excellence/

Sorry my last post was a bit lengthy. However, if this money is sanctioned, and its looking rather positive then the opportunity in India and elsewhere are quite unbelievable.
You can have all the data in the world but if you cant communicate it, and act on it in a timely, secure manner then it loses its benefits.